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Current interest in ARDS, spurred by the lack of an effective therapy, has stimulated the development of a wide variety of animal models, using a range of insults in a range of species, including the rat (Rinaldo et al., 1984) , pig (Steinberg et al., 1983) , dog (Krausz et al., 1981) , sheep (Ebenshade et al., 1979) and primate (Hangen et al., 1987) .
Our objective was the development of a model of ARDS in which the effects of a range of eicosanoidsin the pathogenesis of this syndrome could be readily examined and then compared. Ideally, the model would closely mimic the pathophysiologic characteristics of ARDS and be easily reproducible to allow the comparison of a variety of pharmacologic interventions. For these reasons, we chose an endotoxin model in the rat, and modified the exposure to optimize the pulmonary response.
Endotoxin has been administered intratracheally to rodents (Yap, 1982; Starcher & Williams, 1989) , but usually as a liquid bolus.
In preliminary studies we found that a liquid bolus produced focal lesions with severe haemorrhage and necrosis while a considerable amount of other lung tissue remained unaffected. Accordingly, we developed an intratracheal aerosolization technique which disperses the endotoxin resulting in uniform involvement of the lung. In this report, we describe a method that is simple, reproducible, does not require surgery and allows numbers of rats to be exposed easily to allow treatment comparisons. The endotoxin aerosol produces a neutrophilic alveolitis which has the functional and cellular responses of ARDS in man.
Materials and methods
Male Sprague-Dawley rats obtained from Charles River Laboratories (Raleigh, NC, USA), between 250-350 g were used in this study. All experimental procedures were in accordance with NIH guidelines and were reviewed by the SmithKline and French Animal Care and Use Committee. A Bouin preparation of Salmonella enteritidis endotoxin (LPS) was obtained from Difco (Detroit, MI, USA) and dissolved in endotoxin-free Dulbecco's phosphate buffered saline(PBS), pH == 7 .4.
The atomizer (Penn-Century, Philadelphia, PA, USA) used in these studies consists of a I ml syringe in combination with a miniaturized nozzle mounted on the tip of a 3 in, IS-gauge stainless steel tube ( Fig. lA, B ) and is similar in principle to an ordinary nasal pump spray. When the syringe plunger is depressed, the endotoxin solution is forced at high pressure into a small mixing chamber on the end of the steel tube, thus imparting considerable momentum to the solution. The atomizer thus allows dispersal of a small volume of liquid into the lung without the necessity of a large volume of air to act as a vehicle. This reduction in air volume is essential for this technique, since the aerosol is being sprayed into the relatively small volume of the rat lung.
To allow administration of the LPS aerosol, rats were first anaesthetized with a mixture of 30 mg/kg Ketamine (Bristol Laboratories, Evansville, IN, USA), 3 mg/kg Rompun (Mobay Corp., Shawnee, KS, USA) and 0,5 mg/kg Acepromazine (Ayerst, New York City, NY, USA) as described by Sedgwick (1980) . Following anaesthesia, the rat was placed on its haunches in an upright position in a chair (Harvard Apparatus, South Natick, MA, USA), with its head supported by hooking the incisors over an elastic band (Fig. 2 ). This position facilitated intubation with the aerosolizer tube guided by a fibreoptic light source. Each rat was administered 7 mg/kg LPS delivered in a total volume of O' 5 ml of solution. Using a second aerosolizer, to avoid contamination, another group of rats received endotoxinfree PBS administered as a vehicle control. After administration of the aerosol, the rats were returned to their cages and allowed to recover from anaesthesia.
Three groups of rats were used to characterize this endotoxin model (Table 1) . In Group 1, 31 studies were conducted over 14 days with rats killed at 6 h, 1, 2, 3, 7 and 14 days for histopathological evaluation. Pulmonary function testing was performed on all surviving rats in Group 1 at each time point. Results obtained from the rats in Group 1indicated that maximum functional effects were present 24 h after endotoxin administration. To further characterize the changes at 24 h, additional rats were exposed to LPS to investigate quasi-static compliance (Group 2) and changes in haematology and bronchoalveolar lavage fluid (Group 3).
Assessment of ventilatory parametersl histopathology (Groups 1, 2)
Conscious rats were placed in a standard plexiglass plethysmograph chamber (volume = 5' 8 L) which was partially filled with copper gauze to help maintain isothermal conditions. Pressure changes, measured by a differential pressure transducer (Model MP-45 , Validyne Engineering, Northridge, CA, USA), were used to measure changes in thoracic cavity volume. The pressure signal was analysed by an FDP Analyser (Buxco Electronics Inc., Sharon, CT, USA) and values for tidal volume (V T), respiratory rate (f) and minute ventilation (V E ) were automatically calculated for each breath and averaged every 0·1 min by a Datalogger 12 analogue-digital converter (Buxco Electronics Inc., Sharon, CT, USA). At each interval, recordings were made for an 8 min period during which tracings of VT and airflow were continuously monitored. Movement artefacts, apnoeic episodes and augmented breaths were edited from the data and were not included in the calculations.
To define the relationship between changes in ventilatory parameters and changes in compliance, pressure-flow and pressure-volume forced manoeuvres were performed in 5 endotoxintreated rats and 4 untreated rats using a technique previously described by Diamond and O'Donnell (1977) .
Rats used for the histopathology time course studies in Group 1 were killed with an intraperitoneal injection of sodium pentobarbital followed by exsanguination. The trachea was cannulated and the lungs dissected free of the thoracic wall. Lung fixation was either by intratracheal instillation of 10% formalin (constant pressure of 30 em H 2 0), or by microwave fixation . Following fixation, all tissues were processed using standard histologic methods, sectioned at 5 !-tm, and stained with haematoxylin and eosin or Martius scarlet blue, a specific stain for fibrin (Lendrum, 1962) . Lungs were examined from each of the time points and the severity of the neutrophilic alveoli tis was assessed by histologic examination.
Haematology Ibronchoalveolar lavage procedure (Group 3)
Rats were weighed and bled prior to LPS administration and then immediately prior to euthanasia at 24 h. Blood samples were taken for an estimation of haematocrit (HCT), haemoglobin (Hb), circulating platelet, erythrocyte and leucocyte counts using the ELT-800 Haematology Analyzer (Ortho Diagnostics System Inc., Westwood, MA, USA). Differential circulating leukocyte counts were determined from Wrightstained blood smears. Lung wet-dry (W/0) weights were determined as soon as the lungs were removed following euthanasia (wet weight) and then after drying following BAL (dry weight).
BAL was performed using 50 ml of PBS delivered to the lung in 7-8 ml aliquots. BAL fluid was assayed for total protein (TP), erythrocytes and leukocytes (total and differential). TP was determined using the Biorad protein assay Wheeldon, Walker, Murphy & Turner (Richmond, CA, USA). Total BAL erythrocytes and leukocyte counts were determined using a Coulter counter (Coulter Electronics Inc., Hialeah, FL, USA). Differential cell counts were performed on Wright-Giemsa stained Cytospin preparations (Shandon Southern Instruments Inc., Sewickley, PA, USA). Two hundred cells were identified and counted from random fields at 1000X power. Absolute numbers of each cell type were then calculated.
Statistics
All data are presented as mean ± standard error of the mean treatment among groups unless otherwise specified. Leven's test for homogeneity of variance was performed on the data. If the variances were homogeneous, a one-way ANOVA was performed to analyse the data. If the variances were not homogeneous, the Kruskal-Wallis test was performed. Differences between means were considered to be statistically significant if P<0·05. Figures 3A, B , C show the changes in minute ventilation (VE), respiratory rate (f) and tidal volume (V T), respectively), following LPS or PBS exposure. Baseline values for VE (Fig. 3A) in the two groups did not differ significantly (206-5± 18'10mllmin versus 217·1 ±9'5 mll min, respectively). However, V E was significantly reduced (P<0'05) in the LPS-exposed group (158' 4 ± 7, 9 mllmin) after 24 h, reaching a nadir by 2 days (124'9 ± 5' 84 mllmin) and remaining low for 7 days. By 14 days, V E had returned to baseline values (224' 8 ± 6, 4 mllmin). Figure 3B shows that f only increased significantly after 3 days and remained elevated throughout the remainder of the study period. The change in VT over the l4-day study period is shown in Fig. 3C and closely resembles the pattern for VE' Baseline VT in the 2 groups did not diffeorsignificantly (1 . 17± O' 11ml versus 1·24 ± O' 06 ml, respectively). However, one day after exposure, LPS had caused a significant decrease in VT (0' 86 ± O' 04 ml) which remained 
Results

Ventilatory parameters
Histopathology findings
Lungs examined 6 h after LPS aerosolization had relatively mild oedema involving small clusters of alveoli. Neutrophils were seen in the alveolar walls and there were occasional areas of mild focal haemorrhage. Figures 4A, B , C, compare lung tissue sections from PBS-exposed ( Fig. 4A ) and LPS-exposed tissue 24 h after exposure (Figs 4B, C) . Although PBS stimulates a slight neutrophil influx in the alveolar walls and spaces (Fig. 4A) , LPS produces a far greater influx of neutrophils involving the entire parenchyma (Figs 4B, C) .
Tissues examined after 24 h by microwave fixation revealed abundant exudates along with hyaline membrane formation (Fig. 4C ). Sections stained with Martius Scarlet Blue revealed the presence of widespread fibrin deposits in these membranes.
By 48 h, there was extensive parenchymal involvement with a marked influx of neutrophils. By 72 h, the pulmonary oedema had subsided leaving eosinophilic proteinaceous residues. Irregular areas of consolidation were present as well as a diffuse alveolar wall thickening. Airway epithelium was hyperplastic and in many areas had undergone goblet-cell metaplasia. Finally, by 14 days post aerosolization, the exudative reaction had completely subsided, leaving behind areas of marked perivascular cuffing by mononuclear cells.
Overall, the 24 h time point was judged to have the most severe cellular and exudative responses. However, W /D was significantly elevated (8 '12 ± O' 35) after LPS exposure. Figure 6 illustrates the findings for BAL TP which was significantly increased after PBS exposure (l'53±0'2l mg; P<O'OOOI), compared to that of unexposed lungs (0' 10 ± o·06 mg); however, the increase stimulated by LPS was over twice this increase (3' 13 ± o·86 mg).
Bronchoalveolar lavage cell counts
The BAL cell counts 24 h post exposure are shown in Figs 7 and 8. BAL erythrocyte counts (Fig. 7) were not significantly increased by PBS administration (3 ·81 ± 0,34 X 10 8 JtL) compared to unexposed controls (2'88 ± 0·27 x IOS/JtL), but were significantly increased (P<O'OI) after exposure to LPS (8' 48 ± 0,87 X 10 8 / I-tl). PBS exposure significantly increased the total number of leukocytes (5 .98 ± 1 .41 X 10 7 ) compared to that of unexposed controls (1 ,65 ± O· 13 x 10 7 ). Exposure to LPS produced a massive increase in the BAL leukocyte count (23 ·42 ± 1· 53 x 107; Fig. 8 ). However, alveolar macrophage numbers did not change after treatment with either PBS or LPS the leukocyte increase being due to the marked inf iltration of neutrophils into the lung (Fig. 8) .
BAL neutrophils increased from 0·01 ± 0,005 X 10 7 cells in unexposed lungs to 3' 18 ± 1· 03 X 10 7 cell~in the BAL from PBS exposed rats, to 19'66± 1·66x 10 7 in LPS exposed rats.
Haematology
Haematologic data is shown in Table 3 . LPS administration produced a significant haemoconcentration 24 h postexposure as indicated by elevated Hb and Hct values. Compared to PBS-exposed controls, LPS-exposed rats demonstrated thrombocytopaenia, neutropaenia and lymphopaenia.
Discussion
Intratracheally aerosolized LPS produces a marked neutrophilic alveolitis which has many of the features of human ARDS. The pathogenesis of the lesion has been well characterized using pulmonary function tests and histopathology with maximum changes seen approximately 24 h post aerosolization. This maximal 24 h response has then been further characterized using BAL and haematology. The changes produced at 24 h are profound enough to be consistent with the changes seen in ARDS and so provide a comparable spectrum of changes against which to measure the blocking effects of potential treatment therapies in subsequent studies 1991a,b) .
Profound functional changes were seen at 24 h. Specifically, V E was decreased primarily due to a compromized V T , rather than changes in j. Although we have no direct evidence for hypoxia in this model, the 400/0 reduction in V E suggests that these rats may well have been hypoxic. A decrease in V T can be caused by a variety of factors including a decrease in lung elasticity or compliance. In preliminary experiments, LPS-induced changes in VT, measured by noninvasive plethysmography, were compared with invasive forced pulmonary manoeuvres in the same rats. The decrease in VT observed after LPS administration significantly correlated with the decrease in quasistatic lung compliance (r = O· 82). This decrease in compliance probably resulted from the presence of extensive oedema fluid and inflammatory cell infiltrate in the lung.
The presence of a lowered V T and reduced lung compliance are consistent with the findings of ARDS patients (Modig, 1989) .
One of the hallmarks of ARDS in humans is the presence of pulmonary oedema caused by increased microvascular permeability (Ashbaugh et al., 1967) . We also detected pulmonary oedema, reflected in increased W/D. This oedema was due, at least in part, to increased microvascular permeability as indicated by BAL TP values. The microwave fixation technique allowed us to visualize this fibrin-rich oedema fluid directly in the flooded alveoli. Although in this model, the lung is the site of LPS deposition, changes are not limited to the lung; haematologic responses to LPS include thrombocytopaenia, leukopaenia and haemoconcentration. Profound thrombocytopaenia is a reflection of capillary endothelial damage, resulting in platelet sequestration, also seen in ARDS patients (Weksler & Goldstein, 1980) . There is ample evidenceto suggestthat the stimulus for damage to the capillary endothelium is associated with the presence of inflammatory cells (Staub et al., 1985) , reflected in our model by the massive increase in BAL leukocytes, 87% of which were neutrophils. This is consistent with the findings in ARDS patients (Tate & Repine, 1983) .
In summary, we have used intratracheally aerosolized LPS to develop a model of ARDS in the rat. The technique is quick, consistent and the miniaturized nozzle allows easy intubation if used with a fibreoptic light source. This is a well characterized model of severe pulmonary inflammation against which to investigate and compare the effects of therapeutic interventions. As such, it should be easier to demonstrate significant improvements in pulmonary parameters compared to the subtler changes seen in some other ARDS models. Brigham KL & Meyrick B (1985) Endotoxin and lung injury.
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